• Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

BioPharma News

Biopharmaceutical industry analysis. Credible, reliable, equitable.

Subscribe
  • Home
  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Cardiology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma News
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Subscribe

coronavirus treatment

Posted inClinical Trials, COVID-19, Infections

Adintrevimab: Cure for All Mutant Variants of SARS-CoV-2

by Mark Gubar January 14, 2022September 8, 2022

Adagio Therapeutics’ monoclonal antibody will help fight all variants of the coronavirus.

Posted inClinical Trials, COVID-19, Infections

Ensovibep: Drug for All Variants of Coronavirus Including Omicron

by Mark Gubar January 10, 2022September 8, 2022

Molecular Partners and Novartis believe in the success of DARPins.

Posted inClinical Trials, COVID-19, Infections

Black Seed for Coronavirus Treatment

by Mark Gubar January 6, 2022September 8, 2022

Nigella sativa, or Prophetic medicine, as a possible cure for COVID-19.

Posted inCOVID-19, Infections, New Drugs, Regulatory

MIR 19: Surprising New Drug to Treat Coronavirus

by Mark Gubar December 23, 2021September 8, 2022

A Russian drug for COVID-19 has adopted a powerful RNA interference technology.

Paxlovid (nirmatrelvir + ritonavir).
Posted inCOVID-19, Infections, New Drugs, Regulatory

Paxlovid Approved in the U.S.

by Tanya von Reuss December 22, 2021September 8, 2022

Pfizer’s oral antiviral drug has entered the world’s main pharmaceutical market.

coronavirus
Posted inCOVID-19, Infections, Research

Omicron Variant: Latest Scientific News, Findings, Evidence, and Developments

by Nik Resovski and Timur Burkhanayev December 17, 2021April 11, 2024

Up-to-date scientific information about the new Omicron variant of SARS-CoV-2/COVID-19.

Posted inCOVID-19, Infections, Research

Do People Who Have Already Had COVID-19 Need to Be Vaccinated?

by Tanya von Reuss December 14, 2021April 11, 2024

How long does protective immunity last after a COVID-19 infection?

Posts pagination

Newer posts 1 2 3 Older posts
BioPharma News Logo
Biopharmaceutical industry analysis.
© 2025 BioPharma News Powered by Newspack Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma News

Awareness and enlightenment are strengths.

BioPharma News is an amazing and trustworthy non-profit data analysis service that provides honest and objective reporting on the Pharma & Biotech industry. We would like to invite you to sign up for our weekly Newsletter to stay informed and uptodate.

Please check your inbox or spam folder for an email from [email protected] to confirm your subscription.

×